Background: Psoriasis is a common immune-mediated chronic inflammatory disease of the skin and joints, affecting 1-3% of the population. It is generally accepted that the pathogenesis of psoriasis involves accumulation of effector T-cells within lymph nodes and their subsequent migration into the skin through the blood system. Here we provide evidence that psoriatic plaque itself may serve as a source of inflammatory T-cells. oBjective: We examined the intradermal proliferation of T-cells and the number of effector/memory (CD45RO+) T-cells in the skin of psoriatic patients at different periods of the disease. Methods: Skin samples were obtained from 41 patients with progressive psoriatic lesions; 18 of these patients also donated skin specimens during the remission of the disease. The control group consisted of 16 healthy subjects. Ki-67 immunohistochemical staining was applied to detect proliferating cells, CD3ε served as a T-cell marker, and CD45RA and CD45RO antibodies were utilized to discriminate between naive and effector/memory T-cells, respectively. results: Progressive psoriatic lesions demonstrated Ki67 staining both in keratinocytes and in the CD3ε+ cells of dermal infiltrate. Median count of CD45RO+ cells per microscopic field was 15 in healthy controls, 59 in patients in remission and 208 in progressive psoriatic plaques. The observed differences demonstrated high level of statistical significance. study liMitations: Limited number of analyzed patients.. conclusion: Progressive phase of psoriasis is characterized by intradermal proliferation of T-cells. Spots of regressed psoriatic lesions contain high number of CD45RO+ cells, which are likely to render an immunological memory.
INTRODUCTION
Psoriasis is a common immune-mediated chronic inflammatory disease of the skin and joints, affecting 1-3% of the population. 1 The pathogenesis of psoriasis involves activation of Langerhans cells in the epidermis followed by their migration into the dermis; these cells subsequently relocate to draining lymph nodes and present antigens to naive T-cells. 2 This model is perfectly compatible with the primary immune response observed at the onset of the disease, e.g. in the guttate psoriasis. Indeed, the development of psoriasis frequently involves inflammation of the pharyngeal lymphoid ring caused by β-hemolytic streptococcus. The latent period of 2-3 weeks is required for the maturation of effector T-cells and hematogenous dissemination of these cells, as evidenced by multifocal lesions. 6, 7 However, the above model fails to explain some aspects of the disease relapse. For example, the recurrence of plaques is usually observed on the same ("favorite") sites, suggesting the existence of topical immunological memory within the skin. Surprisingly, regional lymph nodes always remain intact, irrespectively of the severity of psoriatic relapse. Altogether, these observations put into the question the exclusive role of lymph nodes in producing effector T-cells. We hypothesized that the psoriatic skin itself may serve as a source of antigen-specific T-cells. This report provides evidence to support this assumption.
METHODS

Patients and biopsies
The study included 41 patients with active psoriasis vulgaris (mean age 43.9±12.5 years) who did not receive any systemic or topical treatment at least within 4 weeks prior the examination.
Punch biopsies (6 mm) were obtained from the periphery of psoriatic plaques. 18 of these patients underwent second biopsy in the same skin spot at the time of disease remission. Control samples from 16 healthy individuals included the material leftover after plastic surgeries (mean age 36.1±12.6 years). All recruited subjects were required to sign an informed consent form.
Antibodies and immunohistochemistry
The antibodies used for immunohistochemistry are list- Statistical analysis was performed using the IBM SPSS Statistics, version 20. Wilcoxon-Mann-Whitney test was used to evaluate the differences between the samples of the skin from progressive psoriatic lesions, remission of psoriasis and healthy individuals.
A p-value of less than 0.01 was considered significant.
RESULTS
Median count of Ki67
+ cells per field in the derma of the groups of patients with progressive disease, patients in remission and healthy individuals was 40, 7, and 3, respectively (Table 2) 
